[ad_1]
A new preprint study under review shows how the CBD products market is shaping the consumption of prescription drugs in Italy.
The local availability of cannabis flowers, as known as light cannabis led to a significant decrease of dispensed boxes of anxiolytics by 11.5%, a reduction of sedatives by 10%, and a reduction of antipsychotics by 4.8%. Also, the study found a reduction of consumption of antiepileptics (- 1.5%), antidepressants (-1.2%), opioids (-1.2%), anti-migraines (-1%).
To conduct the study, Italian researchers used a unique longitudinal dataset recording monthly drug sales and mapping the local market availability of retailers selling CBD flowers. They matched the data of 106 Italian provinces from January 2016 to February 2018. CBD product data was acquired using web scraping on the sites that map their online presence in the reference period. Data on prescription drug sales were obtained by the Italian association of pharmacy owners Federfarma and by the…
[ad_2]
This is just an excerpt, please Click here to read content on original website.